These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 14755079)

  • 1. Detection of ERK1/2 activities using affinity reagents.
    Pulido R; Zúñiga A; Ullrich A
    Methods Mol Biol; 2004; 250():49-60. PubMed ID: 14755079
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of MAPK cascades by protein tyrosine phosphatases.
    Torres J; Blanco-Aparicio C; Pulido R
    Methods Mol Biol; 2004; 250():103-12. PubMed ID: 14755083
    [No Abstract]   [Full Text] [Related]  

  • 3. An improved western blotting technique effectively reduces background.
    Wu M; Stockley PG; Martin WJ
    Electrophoresis; 2002 Aug; 23(15):2373-6. PubMed ID: 12210190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of MAPK signaling using knockout mice.
    Pagès G; Pouysségur J
    Methods Mol Biol; 2004; 250():155-66. PubMed ID: 14755087
    [No Abstract]   [Full Text] [Related]  

  • 5. ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.
    Xu Z; Wang BR; Wang X; Kuang F; Duan XL; Jiao XY; Ju G
    Life Sci; 2006 Oct; 79(20):1895-905. PubMed ID: 16978658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
    Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
    Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of SAPKs/JNKs and p38s in vitro.
    Kyriakis JM; Liu H; Chadee DN
    Methods Mol Biol; 2004; 250():61-88. PubMed ID: 14755080
    [No Abstract]   [Full Text] [Related]  

  • 12. ERK1/2 MAP kinases in cell survival and apoptosis.
    Lu Z; Xu S
    IUBMB Life; 2006 Nov; 58(11):621-31. PubMed ID: 17085381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MAP and tyrosine kinase signaling in heterophils from commercial and wild-type turkeys.
    Genovese KJ; He H; Lowry VK; Kogut MH
    Dev Comp Immunol; 2007; 31(9):927-33. PubMed ID: 17241661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of ERK activity: antiphospho-ERK antibodies, in vitro phosphorylation, and in-gel kinase assay.
    Kraus S; Seger R
    Methods Mol Biol; 2004; 250():29-48. PubMed ID: 14755078
    [No Abstract]   [Full Text] [Related]  

  • 16. Assays for mitogen-activated protein kinase (MAPK) subtypes and MAPK activating protein kinase-2 (MAPKAP K-2) using a common cell lysate.
    Le Panse R; Rampersaud N; Mahadevan LC
    Methods Mol Biol; 2001; 124():121-30. PubMed ID: 11100471
    [No Abstract]   [Full Text] [Related]  

  • 17. The phosphothreonine lyase activity of a bacterial type III effector family.
    Li H; Xu H; Zhou Y; Zhang J; Long C; Li S; Chen S; Zhou JM; Shao F
    Science; 2007 Feb; 315(5814):1000-3. PubMed ID: 17303758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development.
    Alonso M; Melani M; Converso D; Jaitovich A; Paz C; Carreras MC; Medina JH; Poderoso JJ
    J Neurochem; 2004 Apr; 89(1):248-56. PubMed ID: 15030409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
    Tárrega C; Pulido R
    Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-intensity pulsed ultrasound on the differentiation of C2C12 cells.
    Ikeda K; Takayama T; Suzuki N; Shimada K; Otsuka K; Ito K
    Life Sci; 2006 Oct; 79(20):1936-43. PubMed ID: 16846618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.